High confidence · Latest 84 of 98 total reviews analyzed · Based on 98 reviews. Signal may be noisy.

Excited

Recent user voice shows a excited sentiment. Users appreciate estimated medication level charts provide actionable insights for managing injection schedules and symptoms, but report paywalling previously free features like medication level charts creates friction for long-term users.

Rating: 4.8

Reviews: 98

Confidence: high

How did the latest release land?

Overall
4.8/ 5
(23.2K)
Current version
4.8/ 5
0.0 vs overall
(23.2K)
Main signal post-update: estimated medication level charts provide actionable insights for managing injection schedules and symptoms.

Sentiment over time

Weekly average rating and review volume across stores, last 90 days.

How have ratings & review volume moved?

Rating, review sentiment, and total reviews over time, with release markers showing the post-launch impact.

Rating over time

Vertical markers = app releases. Hover any release for the post-release impact delta.

Releases:MajorMinorPatch2 releases in range

Review themes

Praise

What users love

  • Estimated medication level charts provide actionable insights for managing injection schedules and symptoms
    • Users value the ability to visualize medication concentration in their system to understand appetite and side effects
Complaint

Common complaints

  • Paywalling previously free features like medication level charts creates friction for long-term users
    • Users express disappointment that core tracking features were moved behind a subscription model
Request

Most requested

  • Integration of milestone photo tracking to visualize physical progress alongside weight loss data
    • Users want a dedicated space to attach progress photos to celebrate their health journey

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with editorial review, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by Shotsy GLP-1 Tracker, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Data licensed under CC-BY-NC 4.0